CVRX logo

CVRX
CVRx Inc

740
Mkt Cap
$160.81M
Volume
66,629.00
52W High
$11.30
52W Low
$4.37
PE Ratio
-3.01
CVRX Fundamentals
Price
$6.07
Prev Close
$6.06
Open
$5.97
50D MA
$7.65
Beta
1.66
Avg. Volume
270,722.36
EPS (Annual)
-$2.04
P/B
5.50
Rev/Employee
$254,040.36
$160.00
Loading...
Loading...
News
all
press releases
CVRx Stock Up on Humana's Medicare Coverage for Barostim Therapy
CVRX stock gains after Humana adds Medicare Advantage coverage for Barostim therapy, boosting reimbursement momentum and patient access.
Zacks·3d ago
News Placeholder
More News
News Placeholder
Down 31.7% in 4 Weeks, Here's Why You Should You Buy the Dip in CVRx (CVRX)
CVRx (CVRX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Zacks·8d ago
News Placeholder
CVRx (CVRX) Reports Q1 Loss, Beats Revenue Estimates
CVRx (CVRX) delivered earnings and revenue surprises of +1.32% and +3.69%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·10d ago
News Placeholder
Pacific Biosciences of California (PACB) Reports Q1 Loss, Lags Revenue Estimates
Pacific Biosciences (PACB) delivered earnings and revenue surprises of +29.41% and -9.32%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·14d ago
News Placeholder
CVRx (CVRX) Projected to Post Quarterly Earnings on Monday
CVRx (NASDAQ:CVRX) will be releasing its Q1 2026 earnings after the market closes on Monday, May 11. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-11-cvrx-inc-stock...
MarketBeat·17d ago
News Placeholder
CVRx (CVRX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
After losing some value lately, a hammer chart pattern has been formed for CVRx (CVRX), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Zacks·20d ago
News Placeholder
CVRx, Inc. (NASDAQ:CVRX) Receives Average Rating of "Moderate Buy" from Analysts
CVRx, Inc. (NASDAQ:CVRX - Get Free Report) has earned an average rating of "Moderate Buy" from the six analysts that are presently covering the company, Marketbeat reports. Two research analysts have rated the stock with a sell recommendation, two have assigned a buy recommendation and two have is...
MarketBeat·26d ago
News Placeholder
CVRx (NASDAQ:CVRX) Earns "Buy" Rating from Canaccord Genuity Group
Canaccord Genuity Group reiterated a "buy" rating and set a $10.00 price objective on shares of CVRx in a research report on Tuesday...
MarketBeat·1mo ago
News Placeholder
CVRx, Inc. (NASDAQ:CVRX) Receives Average Recommendation of "Moderate Buy" from Analysts
CVRx, Inc. (NASDAQ:CVRX - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the seven brokerages that are currently covering the firm, MarketBeat Ratings reports. Two...
MarketBeat·2mo ago
News Placeholder
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Continues Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of CVRx, Inc. (CVRx or the Company) (NASDAQ: CVRX) investors concerning the...
Business Wire·2mo ago
<
1
2
...
>

Latest CVRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.